Skip to main content

Vaccine hopes set against darkening near-term outlook

The continued surge in COVID-19 infections across the country is prompting a growing number of states to reimpose restrictions on activity. The softer retail sales data in October indicated that this is already starting to weigh on the economy and, with high-frequency indicators of services activity pointing to a continued deterioration, the risks to our forecast that GDP growth will slow to 4.5% annualised in the fourth quarter are increasingly skewed to the downside. Next year is shaping up to be a different story, however, with the prospect of highly effective vaccines becoming widely available within the next six months or so potentially giving a boost to economic growth. Alongside a further fiscal stimulus package, which is still a distinct possibility despite the elections failing to deliver the ‘Blue Wave’ that President-elect Joe Biden would have hoped for, the prospects for the economy further ahead are looking increasingly bright.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services


Get access